According to reports, a British researcher has said
that an Ebola vaccine might be available in December.
Dr. Mike Turner told the Punch that his organization,
Wellcome Trust is partnering with the Dangote
Foundation to develop ways to fight the disease.
Dr. Turner is the Head of Infection at the non-
governmental organization which is based in the
United Kingdom and which facilitates medical
research.
that an Ebola vaccine might be available in December.
Dr. Mike Turner told the Punch that his organization,
Wellcome Trust is partnering with the Dangote
Foundation to develop ways to fight the disease.
Dr. Turner is the Head of Infection at the non-
governmental organization which is based in the
United Kingdom and which facilitates medical
research.
He reportedly said:
“We are delighted that the Dangote Foundation is
joining the Wellcome Trust and others in the
international consortium of funders to develop a
multi-pronged approach to combating Ebola.
“This is a fast-moving scene at present and it is not yet
clear precisely which partners will fund which
components of the work that we hope will lead to new
diagnostics, drugs and vaccines.
“What is more important is that the partners are all
not just talking about the problems, but actually trying
to make things happen and the future inevitable
epidemics. If things go well, we hope to know whether
this candidate vaccine is safe, with some prospect of
protecting people by Christmas.
“We are delighted that the Dangote Foundation is
joining the Wellcome Trust and others in the
international consortium of funders to develop a
multi-pronged approach to combating Ebola.
“This is a fast-moving scene at present and it is not yet
clear precisely which partners will fund which
components of the work that we hope will lead to new
diagnostics, drugs and vaccines.
“What is more important is that the partners are all
not just talking about the problems, but actually trying
to make things happen and the future inevitable
epidemics. If things go well, we hope to know whether
this candidate vaccine is safe, with some prospect of
protecting people by Christmas.
”
“The vaccine that is being tested in Oxford, and then in
The Gambia and Mali, is being given to the consortium
by NIH. It was originally developed by a company
called Okairos, which was taken over by GSK last year.
“We are delighted that both NIH and GSK have been
very open to sharing the vaccine and information
about it with Oxford consortium, recognizing that by
sharing we can collectively speed development,”
“The vaccine that is being tested in Oxford, and then in
The Gambia and Mali, is being given to the consortium
by NIH. It was originally developed by a company
called Okairos, which was taken over by GSK last year.
“We are delighted that both NIH and GSK have been
very open to sharing the vaccine and information
about it with Oxford consortium, recognizing that by
sharing we can collectively speed development,”
Turner also reportedly added that the trust is working
with the National Institutes of Health and
GlaxoSmithKline in the US and testing would soon
begin in Oxford, England, as well as two other African
countries.
with the National Institutes of Health and
GlaxoSmithKline in the US and testing would soon
begin in Oxford, England, as well as two other African
countries.
0 comments: